Form 4 for TECH Bio-Techne
Accepted 2024-07-25 00:00:00 ET · period of report 2024-07-23 · accession 0001062993-24-014086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-25 | 2024-07-23 | TECH | Hippel James | CFO | M - OptEx | $31.26 | +35.0K | 107.3K | +48% | +$1.09M |
| D | 2024-07-25 | 2024-07-23 | TECH | Hippel James | CFO | F - Tax | $77.77 | -24.3K | 83.0K | -23% | -$1.89M |
| D | 2024-07-25 | 2024-07-23 | TECH | Hippel James | CFO | M - OptEx | $0.00 | -35.0K | 106.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-23 | M | A | 35,000 | $31.26 | 107,284 | D | — | — | (F1) The Reporting Person's direct ownership has been increased by 400 shares pursuant to a clerical error in a previous filing. |
| 2 | Common | Common Stock | 2024-07-23 | F | D | 24,282 | $77.77 | 83,002 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-07-23 | M | D | 35,000 | $0.00 | 106,867 | D | $31.26 · — to 2024-08-09 | 35,000 Common Stock | (F2) Fully exercisable. |